These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 7591320)
21. Efegatran sulfate as an adjunct to streptokinase versus heparin as an adjunct to tissue plasminogen activator in patients with acute myocardial infarction. ESCALAT Investigators. Fung AY; Lorch G; Cambier PA; Hansen D; Titus BG; Martin JS; Lee JJ; Every NR; Hallstrom AP; Stock-Novack D; Scherer J; Weaver WD Am Heart J; 1999 Oct; 138(4 Pt 1):696-704. PubMed ID: 10502216 [TBL] [Abstract][Full Text] [Related]
22. New developments in thrombolytic therapy. Collen D; Gold HK Verh K Acad Geneeskd Belg; 1989; 51(3):191-228; discussion 229. PubMed ID: 2686261 [TBL] [Abstract][Full Text] [Related]
23. New developments in thrombolytic therapy. Collen D; Gold HK Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372 [TBL] [Abstract][Full Text] [Related]
24. Patency trials with reteplase (r-PA): what do they tell us? Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406 [TBL] [Abstract][Full Text] [Related]
29. Medical therapy of acute myocardial infarction: Part I. Role of thrombolytic and antithrombotic therapy. Jafri SM; Walters BL; Borzak S J Intensive Care Med; 1995; 10(2):54-63. PubMed ID: 10172420 [TBL] [Abstract][Full Text] [Related]
30. Thrombolytic therapy in Europe: current status. Vahanian A Eur Heart J; 1996 Sep; 17 Suppl E():21-7. PubMed ID: 11824000 [TBL] [Abstract][Full Text] [Related]
31. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. White HD; Barbash GI; Califf RM; Simes RJ; Granger CB; Weaver WD; Kleiman NS; Aylward PE; Gore JM; Vahanian A; Lee KL; Ross AM; Topol EJ Circulation; 1996 Oct; 94(8):1826-33. PubMed ID: 8873656 [TBL] [Abstract][Full Text] [Related]
33. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction. Collins R; Peto R; Baigent C; Sleight P N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095 [No Abstract] [Full Text] [Related]
34. [Aspirin and heparin in the fibrinolytic treatment of acute myocardial infarction]. López Bescós L Rev Esp Cardiol; 1992; 45 Suppl 2():21-8. PubMed ID: 1475505 [TBL] [Abstract][Full Text] [Related]
35. Efficacy of streptokinase, but not tissue-type plasminogen activator, in achieving 90-minute patency after thrombolysis for acute myocardial infarction decreases with time to treatment. PERM Study Group. Prospective Evaluation of Reperfusion Markers. Steg PG; Laperche T; Golmard JL; Juliard JM; Benamer H; Himbert D; Aubry P J Am Coll Cardiol; 1998 Mar; 31(4):776-9. PubMed ID: 9525545 [TBL] [Abstract][Full Text] [Related]
36. [Thrombolytic treatment during the acute phase of myocardial infarction. An important reduction of early and secondary mortality]. Charbonnier B Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):697-705. PubMed ID: 1530411 [TBL] [Abstract][Full Text] [Related]
37. Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. Granger CB; Becker R; Tracy RP; Califf RM; Topol EJ; Pieper KS; Ross AM; Roth S; Lambrew C; Bovill EG J Am Coll Cardiol; 1998 Mar; 31(3):497-505. PubMed ID: 9502626 [TBL] [Abstract][Full Text] [Related]
39. [Prescription of heparin in the acute phase of myocardial infarction: expected and observed benefits...]. Cador R; Weber S Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1479-84. PubMed ID: 9092406 [TBL] [Abstract][Full Text] [Related]
40. Comparison of front-loaded recombinant tissue-type plasminogen activator, anistreplase and combination thrombolytic therapy for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 4 trial. Cannon CP; McCabe CH; Diver DJ; Herson S; Greene RM; Shah PK; Sequeira RF; Leya F; Kirshenbaum JM; Magorien RD J Am Coll Cardiol; 1994 Dec; 24(7):1602-10. PubMed ID: 7963104 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]